Literature DB >> 11485928

Modulation of chagasic cardiomyopathy by interleukin-4: dissociation between inflammation and tissue parasitism.

M B Soares1, K N Silva-Mota, R S Lima, M C Bellintani, L Pontes-de-Carvalho, R Ribeiro-dos-Santos.   

Abstract

Chronic chagasic cardiomyopathy (CChC) is characterized by an inflammatory reaction which may eventually lead to heart enlargement, arrythmia, and death. As described herein, interleukin-4-deficient mice mount increased specific T helper (Th) 1 immune responses when infected with Trypanosoma cruzi, as compared to wild-type mice. Interestingly, these mice had reduced parasitism and mortality and exacerbated inflammation in their hearts, demonstrating a clear dissociation between inflammation and parasite load. The modulation of these phenomena so as to maximize host and parasite survivals may depend on a fine balance between Th responses, in which a Th1 response will, on one hand, control parasitism and, on the other hand, enhance heart inflammation throughout the course of the infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11485928      PMCID: PMC1850539          DOI: 10.1016/S0002-9440(10)61741-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

Review 1.  The role of the immune response on the development of severe clinical forms of human Chagas disease.

Authors:  R Corrêa-Oliveira; J Gomes; E M Lemos; G M Cardoso; D D Reis; S Adad; E Crema; O A Martins-Filho; M O Costa; G Gazzinelli; L M Bahia-Oliveira
Journal:  Mem Inst Oswaldo Cruz       Date:  1999       Impact factor: 2.743

2.  CHRONIC AND PROGRESSIVE MYOCARDITIS AND MYOSITIS IN C3H MICE INFECTED WITH TRYPANOSOMA CRUZI.

Authors:  E E FEDERICI; W H ABELMANN; F A NEVA
Journal:  Am J Trop Med Hyg       Date:  1964-03       Impact factor: 2.345

3.  Influence of Trypanosoma cruzi strain on the pathogenesis of chronic myocardiopathy in mice.

Authors:  S G Andrade
Journal:  Mem Inst Oswaldo Cruz       Date:  1990 Jan-Mar       Impact factor: 2.743

Review 4.  Role of autoreactive immunological mechanisms in chagasic carditis.

Authors:  R Ribeiro-dos-Santos; C Pirmez; W Savino
Journal:  Res Immunol       Date:  1991-02

5.  Trypanosoma cruzi: cytokine effects on macrophage trypanocidal activity.

Authors:  J M Golden; R L Tarleton
Journal:  Exp Parasitol       Date:  1991-05       Impact factor: 2.011

6.  Effects of interleukin-4 deprivation and treatment on resistance to Trypanosoma cruzi.

Authors:  I A Abrahamsohn; A P da Silva; R L Coffman
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

7.  Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice.

Authors:  F Torrico; H Heremans; M T Rivera; E Van Marck; A Billiau; Y Carlier
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

8.  Endogenous interferon-gamma, macrophage activation, and murine host defense against acute infection with Trypanosoma cruzi.

Authors:  R E McCabe; S G Meagher; B T Mullins
Journal:  J Infect Dis       Date:  1991-04       Impact factor: 5.226

9.  In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.

Authors:  S G Reed
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

10.  Anti-CD4 abrogates rejection and reestablishes long-term tolerance to syngeneic newborn hearts grafted in mice chronically infected with Trypanosoma cruzi.

Authors:  R R dos Santos; M A Rossi; J L Laus; J S Silva; W Savino; J Mengel
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

View more
  20 in total

1.  Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection.

Authors:  V Michailowsky; N M Silva; C D Rocha; L Q Vieira; J Lannes-Vieira; R T Gazzinelli
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

2.  Vaccine-Linked Chemotherapy Improves Benznidazole Efficacy for Acute Chagas Disease.

Authors:  Kathryn Jones; Leroy Versteeg; Ashish Damania; Brian Keegan; April Kendricks; Jeroen Pollet; Julio Vladimir Cruz-Chan; Fabian Gusovsky; Peter J Hotez; Maria Elena Bottazzi
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

3.  Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients.

Authors:  Juliana A S Gomes; Lilian M G Bahia-Oliveira; Manoel Otávio C Rocha; Solange C U Busek; Mauro M Teixeira; João Santana Silva; Rodrigo Correa-Oliveira
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

4.  Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy.

Authors:  Edecio Cunha-Neto; Victor J Dzau; Paul D Allen; Dimitri Stamatiou; Luiz Benvenutti; M Lourdes Higuchi; Natalia S Koyama; Joao S Silva; Jorge Kalil; Choong-Chin Liew
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

5.  Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.

Authors:  Simone Garcia; Carolina O Ramos; Juliana F V Senra; Fabio Vilas-Boas; Maurício M Rodrigues; Antonio C Campos-de-Carvalho; Ricardo Ribeiro-Dos-Santos; Milena B P Soares
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

6.  Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response.

Authors:  J A S Gomes; L M G Bahia-Oliveira; M O C Rocha; O A Martins-Filho; G Gazzinelli; R Correa-Oliveira
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

7.  Depletion of regulatory T cells decreases cardiac parasitosis and inflammation in experimental Chagas disease.

Authors:  Kevin M Bonney; Joann M Taylor; Edward B Thorp; Conrad L Epting; David M Engman
Journal:  Parasitol Res       Date:  2015-01-11       Impact factor: 2.289

Review 8.  Computational modeling of cardiac fibroblasts and fibrosis.

Authors:  Angela C Zeigler; William J Richardson; Jeffrey W Holmes; Jeffrey J Saucerman
Journal:  J Mol Cell Cardiol       Date:  2015-12-01       Impact factor: 5.000

9.  Curcumin Enhances the Anti-Trypanosoma cruzi Activity of Benznidazole-Based Chemotherapy in Acute Experimental Chagas Disease.

Authors:  Rômulo Dias Novaes; Marcus Vinicius Pessoa Sartini; João Paulo Ferreira Rodrigues; Reggiani Vilela Gonçalves; Eliziária Cardoso Santos; Raquel Lopes Martins Souza; Ivo Santana Caldas
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

Review 10.  Nano-Medicines a Hope for Chagas Disease!

Authors:  Satabdi Datta Choudhury
Journal:  Front Mol Biosci       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.